朝聚眼科(02219.HK)完成收購北京明玥眼科診所97%股權
格隆匯1月2日丨朝聚眼科(02219.HK)公吿,於2023年12月25日,廈門朝聚樂通控股有限公司("廈門朝聚樂通")及廈門聚望明暉投資合夥企業(有限合夥)("廈門聚望")(均為公司間接全資附屬公司)已完成收購北京明玥眼科診所有限公司("北京醫院")97%股權,代價為人民幣36.86百萬元。
於此次收購中,(i)廈門朝聚樂通自公司獨立第三方於夢圓收購北京醫院51%股權;以及(ii)廈門聚望自於夢圓收購北京醫院10.29%股權及自公司獨立第三方泰華東億(北京)科技發展有限公司收購北京醫院35.71%股權。北京醫院餘下3%股權由公司獨立第三方個人持有。於完成該收購事項後,北京醫院的業績將於集團的財務報表合併入賬。
北京醫院位於北京市,為集團帶來戰略利益,原因是其將成為集團在中國北方地區的資源整合平台。集團將能夠與其於蒙東、蒙西、河北、山西及寧夏區域內的各家醫院集羣化運作產生協同效應,乃因彼等將合作並擴大其覆蓋範圍,這對其未來在華北核心區域和北方其他區域的發展甚為重要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.